The board of directors of Dawnrays Pharmaceutical (Holdings) Limited announced that Mr. EDE, Ronald Hao Xi has been appointed as a non-executive director of the Company, such appointment to take effect from 15 June 2015. Mr. EDE, Ronald Hao Xi has extensive experience in financial and business management in multinational companies. He currently holds the position of chief financial officer and company secretary of Biosensors International Group Ltd. He is also an independent director and a member of the audit committee and transactions committee of Mindray Medical International Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 HKD | +1.68% | +3.42% | +15.24% |
Mar. 26 | Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024 | CI |
Mar. 25 | Dawnrays' 2023 Profit Falls 9% on Lower Revenue | MT |
1st Jan change | Capi. | |
---|---|---|
+15.24% | 232M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 2348 Stock
- News Dawnrays Pharmaceutical (Holdings) Limited
- Dawnrays Pharmaceutical Holdings Ltd. Appoints EDE, Ronald Hao Xi as Non-Executive Director, Effective from June 15, 2015